Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Vaccine|March 4, 2014
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013Ian G Barr, Colin Russell, Terry G Besselaar, et al.Frontiers in Immunology|May 5, 2023
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative studyJoanna Waldock, Edmond J Remarque, Lingyi Zheng, et al.Frontiers in Immunology|July 5, 2022
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative StudyMarie-Clotilde Bernard, Joanna Waldock, Sylvie Commandeur, et al.Vaccine|April 16, 2009
Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UKPhilip D Minor, Othmar G Engelhardt, John M Wood, et al.Frontiers in Immunology|February 21, 2025
Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studiesCamilla T Ekanger, Nilima Dinesh Kumar, Rosanne W Koutstaal, et al.Biologicals : Journal of the International Association of Biological Standardization|February 3, 2024
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting reportNicoletta Corti, Christopher Chiu, Rebecca J Cox, et al.Vaccines|November 13, 2020
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive AntibodiesJuan Manuel Carreño, Jacqueline U McDonald, Tara Hurst, et al.Frontiers in Immunology|March 17, 2023
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP studyJoanna Waldock, Carol D Weiss, Wei Wang, et al.Biologicals : Journal of the International Association of Biological Standardization|January 17, 2025
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting reportIrina Meln, Victor Cnossen, Nicoletta Corti, et al.Vaccine|January 5, 2011
The development of vaccine viruses against pandemic A(H1N1) influenzaJames S Robertson, Carolyn Nicolson, Ruth Harvey, et al.Pageof 6